339 related articles for article (PubMed ID: 27179178)
1. Synthesis and biological evaluation of novel pyrazolopyrimidines derivatives as anticancer and anti-5-lipoxygenase agents.
Rahmouni A; Souiei S; Belkacem MA; Romdhane A; Bouajila J; Ben Jannet H
Bioorg Chem; 2016 Jun; 66():160-8. PubMed ID: 27179178
[TBL] [Abstract][Full Text] [Related]
2. Induction of intrinsic apoptosis pathway in colon cancer HCT-116 cells by novel 2-substituted-5,6,7,8-tetrahydronaphthalene derivatives.
Gamal-Eldeen AM; Hamdy NA; Abdel-Aziz HA; El-Hussieny EA; Fakhr IM
Eur J Med Chem; 2014 Apr; 77():323-33. PubMed ID: 24657569
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, EGFR Inhibition and Anti-cancer Activity of New 3,6-dimethyl-1-phenyl-4-(substituted-methoxy)pyrazolo[3,4-d] pyrimidine Derivatives.
Bakr RB; Mehany ABM; Abdellatif KRA
Anticancer Agents Med Chem; 2017; 17(10):1389-1400. PubMed ID: 28270084
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in-vitro anti-proliferative evaluation of some pyrazolo[1,5-a]pyrimidines as novel larotrectinib analogs.
Attia MH; Elrazaz EZ; El-Emam SZ; Taher AT; Abdel-Aziz HA; Abouzid KAM
Bioorg Chem; 2020 Jan; 94():103458. PubMed ID: 31785854
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, cytotoxic, anti-lipoxygenase and anti-acetylcholinesterase capacities of novel derivatives from harmine.
Filali I; Belkacem MA; Ben Nejma A; Souchard JP; Ben Jannet H; Bouajila J
J Enzyme Inhib Med Chem; 2016; 31(sup1):23-33. PubMed ID: 27028352
[TBL] [Abstract][Full Text] [Related]
6. A convenient synthesis and molecular modeling study of novel pyrazolo[3,4-d]pyrimidine and pyrazole derivatives as anti-tumor agents.
Nassar IF; Atta-Allah SR; Elgazwy AS
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):396-405. PubMed ID: 25068728
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of pyrazolo[4,3-d]pyrimidine analogues.
Yuan L; Song C; Li C; Li Y; Dong L; Yin S
Eur J Med Chem; 2013 Sep; 67():152-7. PubMed ID: 23851116
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological evaluation of novel 1,2,3-triazole linked coumarinopyrazole conjugates as potent anticholinesterase, anti-5-lipoxygenase, anti-tyrosinase and anti-cancer agents.
Chekir S; Debbabi M; Regazzetti A; Dargère D; Laprévote O; Ben Jannet H; Gharbi R
Bioorg Chem; 2018 Oct; 80():189-194. PubMed ID: 29940340
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, cytotoxicity, antimicrobial and anti-biofilm activities of novel pyrazolo[3,4-b]pyridine and pyrimidine functionalized 1,2,3-triazole derivatives.
Nagender P; Malla Reddy G; Naresh Kumar R; Poornachandra Y; Ganesh Kumar C; Narsaiah B
Bioorg Med Chem Lett; 2014 Jul; 24(13):2905-8. PubMed ID: 24835633
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and anticancer evaluation of novel pyrazole, pyrazolo[3,4-d]pyrimidine and their glycoside derivatives.
Nassar IF; El Farargy AF; Abdelrazek FM; Ismail NSM
Nucleosides Nucleotides Nucleic Acids; 2017 Apr; 36(4):275-291. PubMed ID: 28323527
[TBL] [Abstract][Full Text] [Related]
11. RETRACTED: Design, synthesis, structure-activity relationship and kinase inhibitory activity of substituted 3-methyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ones.
Lamie PF
Bioorg Med Chem Lett; 2016 Jul; 26(13):3093-3097. PubMed ID: 27189674
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and computational studies on dihydropyrimidine scaffolds as potential lipoxygenase inhibitors and cancer chemopreventive agents.
Venugopala KN; Govender R; Khedr MA; Venugopala R; Aldhubiab BE; Harsha S; Odhav B
Drug Des Devel Ther; 2015; 9():911-21. PubMed ID: 25733811
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and anticancer activity of some new pyrazolo[3,4-d]pyrimidin-4-one derivatives.
Abdellatif KR; Abdelall EK; Abdelgawad MA; Ahmed RR; Bakr RB
Molecules; 2014 Mar; 19(3):3297-309. PubMed ID: 24647032
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of new isoxazoline derivatives from harmine and evaluation of their anti-Alzheimer, anti-cancer and anti-inflammatory activities.
Filali I; Bouajila J; Znati M; Bousejra-El Garah F; Ben Jannet H
J Enzyme Inhib Med Chem; 2015 Jun; 30(3):371-6. PubMed ID: 25068731
[TBL] [Abstract][Full Text] [Related]
15. Pyrazolo[3,4-d]pyrimidine-based dual EGFR T790M/HER2 inhibitors: Design, synthesis, structure-activity relationship and biological activity as potential antitumor and anticonvulsant agents.
Lamie PF; El-Kalaawy AM; Abdel Latif NS; Rashed LA; Philoppes JN
Eur J Med Chem; 2021 Mar; 214():113222. PubMed ID: 33545637
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, antimicrobial and anti-cancer activities of some new N-ethyl, N-benzyl and N-benzoyl-3-indolyl heterocycles.
El-Sawy ER; Mandour AH; Mahmoud K; Islam IE; Abo-Salem HM
Acta Pharm; 2012 Jun; 62(2):157-79. PubMed ID: 22750815
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of some novel pyrazolopyrimidines incorporating a benzothiazole ring system.
Azam MA; Dharanya L; Mehta CC; Sachdeva S
Acta Pharm; 2013 Mar; 63(1):19-30. PubMed ID: 23482310
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, anticancer and radioprotective activities of some new pyrazolo[3,4-d]pyrimidines containing amino acid moieties.
Ghorab MM; Ragab FA; Noaman E; Heiba HI; Aboulmagd SA
Arzneimittelforschung; 2009; 59(2):96-103. PubMed ID: 19338140
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine kinase inhibition effects of novel Pyrazolo[1,5-a]pyrimidines and Pyrido[2,3-d]pyrimidines ligand: Synthesis, biological screening and molecular modeling studies.
El Sayed MT; Hussein HAR; Elebiary NM; Hassan GS; Elmessery SM; Elsheakh AR; Nayel M; Abdel-Aziz HA
Bioorg Chem; 2018 Aug; 78():312-323. PubMed ID: 29625271
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationship studies of pyrazolo[3,4-d]pyrimidine derivatives leading to the discovery of a novel multikinase inhibitor that potently inhibits FLT3 and VEGFR2 and evaluation of its activity against acute myeloid leukemia in vitro and in vivo.
Yang LL; Li GB; Ma S; Zou C; Zhou S; Sun QZ; Cheng C; Chen X; Wang LJ; Feng S; Li LL; Yang SY
J Med Chem; 2013 Feb; 56(4):1641-55. PubMed ID: 23362959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]